Preference for subcutaneous or intravenous administration of trastuzumab in patients with HER2-positive early breast cancer (PrefHer): an open-label randomised study
Titel:
Preference for subcutaneous or intravenous administration of trastuzumab in patients with HER2-positive early breast cancer (PrefHer): an open-label randomised study
Auteur:
Pivot, Xavier Gligorov, Joseph Müller, Volkmar Barrett-Lee, Peter Verma, Sunil Knoop, Ann Curigliano, Giuseppe Semiglazov, Vladimir López-Vivanco, Guillermo Jenkins, Valerie Scotto, Nana Osborne, Stuart Fallowfield, Lesley